Both studies were presented at the American College of Rheumatology (ACR) annual meeting.

The use of biologic and targeted therapies for children with juvenile idiopathic arthritis (JIA) surpassed more typical therapies in recent years, according to researchers.

Sixty-nine-year-old Mary Anne Laporte was diagnosed with knee arthritis 15 years ago. For years, she kept the pain under control with steroid injections and physical therapy, but when she began ...

Objectives Secondary prevention of rheumatoid arthritis (RA) is generally considered potentially impactful because the entire ...

Many types of medications, including over-the-counter (OTC) and prescription drugs, can help relieve joint pain due to ...

Arthritis is a common acute or chronic condition affecting the joints and surrounding tissues. It’s estimated that roughly 18 ...

chiron has developed an advanced organ-on chip technology, which comprises placing of human cells on chips - eg. cells present in the joint - to test the efficacy of drugs. This ground-breaking ...

A 1-year course of methotrexate may help prevent the development of ACPA-negative RA among patients with clinically suspect arthralgia at high-risk for the disease.

The FDA has expanded the approval of Jylamvo (methotrexate) to include the treatment of pediatric patients with acute lymphoblastic leukemia.

Patients on methotrexate should take folic acid supplements under ... lupus, juvenile idiopathic arthritis, psoriasis, ...

Rituximab and methotrexate (MTX) both delayed the onset of RA ... “If you look at all the people who get rheumatoid arthritis, there’s probably no way those could have the same exact pathways,” he ...

In a groundbreaking new study, the active ingredient in Ozempic was found to be so effective at treating arthritis that ...